Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index; 2 of the 16 sources its claims cite were checked for support.
Abstract
The aim of this critical review was to outline emerging trends and perspectives of clinical pharmacopsychology, an area of clinical psychology that is concerned with the psychological effects of medications. The historical development of clinical pharmacopsychology is outlined, with discussion of its most representative expressions and reference to current challenges of clinical research, with particular reference to clinimetrics. The domains of clinical pharmacopsychology encompass the clinical benefits of psychotropic drugs, the characteristics that predict responsiveness to treatment, the vulnerabilities induced by treatment (side effects, behavioral toxicity, iatrogenic comorbidity), and the interactions between drug treatment and psychological variables. Its aim is to provide a comprehensive assessment of the clinical important changes that are concerned with (a) wanted and expected treatment effects, (b) treatment-induced unwanted side effects, and (c) the patient's own personal experience of a change in terms of well-being and/or quality of life. Clinical pharmacopsychology offers a unifying framework for the understanding of clinical phenomena in medical and psychiatric settings. Research in this area deserves high priority.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 3 Not valid · 8 Not checked · 10 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The UKU [57] is an example of a scale that considerably improved the detection of side effects because of its comprehensive nature.”
What the sources say
- Could not verifycites [57] matched to “The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: A meta-analysis of the sequential model and a critical review of the literature” (2016) sourceExperimental — accuracy not yet measured
The Data Synthesis section describes relapse and recurrence as the meta-analysis’s primary outcome, not detection of side effects. Searches for the UKU scale and side-effect detection found no passage in our copy addressing the scale’s comprehensiveness or its effect on detection; the available passages therefore cannot verify the claim. (LLM, conf=0.76)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“the history of toxicology reminds us vividly of the lag that often occurs between the first introduction of a drug into humans and the recognition of certain adverse events from that drug.”
What the sources say
- Could not verifycites [60] matched to “Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial” (2003) sourceExperimental — accuracy not yet measured
The Method and Maintenance of treatment effect sections examine sertraline treatment and outcomes through a one-year follow-up. Searches for delayed recognition of adverse events and drug safety found no passage addressing the interval between a drug’s first use in humans and recognition of its adverse events. The reported deterioration after treatment is not a claim about when adverse events were discovered. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The achievement of such balance is hindered by the varying quality and availability of different sources of information, which lead to a faulty clinical integration.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The assessment of the adverse events is certainly the neglected side of the triangle.”
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“a high correlation does not indicate similar sensitivity.”
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
6 more claims
Create a free account to see all 21 claims and to verify the 14 references still open.
- Probably not a substantial claim. 6
- It may state two separate claims as one. 4
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, trial designs that assess the effects of discontinuing antidepressant drugs for inferring efficacy (i.e., a significant increase in depressive symptoms in the patients whose medications are discontinued and switched to placebo compared to those who continue with treatment) are flawed by lack of consideration and proper assessment of withdrawal events [74].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [74]
Experimental — accuracy not yet measured
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
The WHO-5 well-being index: A systematic review of the literature
Topp, C. W., Østergaard, S. D., Søndergaard, S., & Bech, P. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000376585 · Cited by 4,708
Self-citationGarnefski, N., Kraaij, V., Schroevers, M. J., & Somsen, G. A. (2008) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-008-9136-5 · Cited by 2,479
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Self-citationBarlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
The Hopkins Symptom Checklist (HSCL)
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395070 · Cited by 894
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Self-citationMarks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478
Fava, M., Evins, A. E., Dorer, D. J., & Schoenfeld, D. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000069738 · Cited by 452
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Self-citationAdverse Drug Reactions: A Critical Review
Karch, F. E. (1975) · JAMA · doi:10.1001/jama.1975.03260250028021 · Cited by 335
Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323
Depression Rating Scales: A Critical Review
Carroll, B. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750330049009 · Cited by 314
Mental Pain and Suicide: A Systematic Review of the Literature
Verrocchio, M. C., Carrozzino, D., Marchetti, D., Andreasson, K., Fulcheri, M., & Bech, P. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00108 · Cited by 297
Self-citationAntidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
A Comparison of Depression Rating Scales
Kearns, N. P., Cruickshank, C. A., McGuigan, K. J., Riley, S. A., Shaw, S. P., & Snaith, R. P. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.141.1.45 · Cited by 271
Clinimetrics: the science of clinical measurements
Fava, G. A., Tomba, E., & Sonino, N. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02825.x · Cited by 233
Self-citationThe responsiveness of the Hamilton Depression Rating Scale
Faries, D., Herrera, J., Rayamajhi, J., DeBrota, D., Demitrack, M., & Potter, W. Z. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00037-0 · Cited by 232
Exactly what does the Hamilton depression rating scale measure?
Gibbons, R. D., Clark, D. C., & Kupfer, D. J. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90037-3 · Cited by 223
T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics.
Feinstein, A. R. (1982) · Circulation · doi:10.1161/01.cir.66.1.1 · Cited by 220
Bottomley, A., Jones, D., & Claassens, L. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.032 · Cited by 216
Getting What You Ask For: On the Selectivity of Depression Rating Scales
Demyttenaere, K., & De Fruyt, J. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068690 · Cited by 206
Patient-Centered Outcomes Research Institute: The Intersection of Science and Health Care
Clancy, C., & Collins, F. S. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001235 · Cited by 190
The Brief Psychiatric Rating Scale in Psychopharmacology Research
Overall, J. E. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395069 · Cited by 188
Fava, G. A., & Bech, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000441244 · Cited by 176
Self-citationGuidi, J., Tomba, E., & Fava, G. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040476 · Cited by 167
Self-citationNew Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial
Haug, T. T., Blomhoff, S., Hellstrøm, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.4.312 · Cited by 151
The Clinical Process in Psychiatry: A Clinimetric Approach
Fava, G. A., Rafanelli, C., & Tomba, E. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06444 · Cited by 143
Self-citationPsychometric Theory Is an Obstacle to the Progress of Clinical Research
Fava, G. A., Ruini, C., & Rafanelli, C. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076451 · Cited by 140
Self-citationTossani, E. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000343003 · Cited by 137
Timmerby, N., Andersen, J. H., Søndergaard, S., Østergaard, S. D., & Bech, P. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000457131 · Cited by 134
Self-citationClinimetrics and Clinical Psychometrics: Macro- and Micro-Analysis
Tomba, E., & Bech, P. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000341757 · Cited by 124
Self-citationKraepelin, E. (1892) · Cited by 123
The Concept of Recovery in Affective Disorders
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289025 · Cited by 113
Self-citationPart 2. Improvement criteria in drug trials with neurotic patients
Kellner, R. (1972) · Psychological Medicine · doi:10.1017/s0033291700045645 · Cited by 103
Social Functioning: Should it Become an Endpoint in Trials of Antidepressants?
Bech, P. (2005) · CNS Drugs · doi:10.2165/00023210-200519040-00004 · Cited by 88
Self-citationNon-Specific Factors in Drug Therapy.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-2-434_2 · Cited by 80
New Modalities of Assessment and Treatment Planning in Depression: The Sequential Approach
Fava, G. A., & Tomba, E. (2010) · CNS Drugs · doi:10.2165/11531580-000000000-00000 · Cited by 80
Self-citationThe Clinical Interview for Depression: A Comprehensive Review of Studies and Clinimetric Properties
Guidi, J., Fava, G. A., Bech, P., & Paykel, E. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000317532 · Cited by 79
Self-citationUse of the Psychosocial Index: A Sensitive Tool in Research and Practice
Piolanti, A., Offidani, E., Guidi, J., Gostoli, S., Fava, G. A., & Sonino, N. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447760 · Cited by 79
Self-citationModern Psychometrics in Clinimetrics: Impact on Clinical Trials of Antidepressants
Bech, P. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076448 · Cited by 73
Self-citationThe Clinical Utility of the Diagnostic Criteria for Psychosomatic Research: A Review of Studies
Porcelli, P., & Guidi, J. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000430788 · Cited by 72
Nordahl, H. M., Vogel, P. A., Morken, G., Stiles, T. C., Sandvik, P., & Wells, A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447013 · Cited by 64
Orbach, I. (2003) · PubMed · Cited by 63
Fava, G. A., Guidi, J., Rafanelli, C., & Sonino, N. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000366041 · Cited by 62
Self-citationCOMBINED PHARMACOTHERAPY AND PSYCHOTHERAPY: CONTROLLED STUDIES
UHLENHUTH, E. H., LIPMAN, R. S., & COVI, L. (1969) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196901000-00006 · Cited by 61
Rothschild, A. J., Raskin, J., Wang, C.-N., Marangell, L. B., & Fava, M. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.08.008 · Cited by 59
Richardson, W. S., & Doster, L. M. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.10.020 · Cited by 55
Measurement of Psychological Distress and Well-Being
Bech, P. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288382 · Cited by 55
Self-citationBehavioral Toxicity Revisited: Iatrogenic Comorbidity in Psychiatric Evaluation and Treatment
Fava, G. A., Cosci, F., Offidani, E., & Guidi, J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000570 · Cited by 55
Self-citation境, 洋. (2001) · Medical Entomology and Zoology · Cited by 53
Therapeutic Alliance in Antidepressant Treatment: Cause or Effect of Symptomatic Levels?
Zilcha-Mano, S., Roose, S. P., Barber, J. P., & Rutherford, B. R. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000379756 · Cited by 50
Survey of Treatment Practices for Sexual Dysfunction(s) Associated with Anti-Depressants
Balon, R., & Segraves, R. T. (2008) · Journal of Sex & Marital Therapy · doi:10.1080/00926230802096390 · Cited by 49
From the Serotonin Model of Suicide to a Mental Pain Model of Suicide
de Leon, J., Baca-García, E., & Blasco-Fontecilla, H. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000438510 · Cited by 45
Blasco-Fontecilla, H., Baca-García, E., Courtet, P., García Nieto, R., & de Leon, J. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000369937 · Cited by 44
Reliability and validity of the Symptoms of Depression Questionnaire (SDQ)
Pedrelli, P., Blais, M. A., Alpert, J. E., Shelton, R. C., Walker, R. S. W., & Fava, M. (2014) · CNS Spectrums · doi:10.1017/s1092852914000406 · Cited by 42
A new clinical taxonomy for rating change in functional activities of patients with angina pectoris
Feinstein, A. R., & Wells, C. K. (1977) · American Heart Journal · doi:10.1016/s0002-8703(77)80308-6 · Cited by 41
Clinimetric Dilemmas in Outcome Scales for Mental Disorders
Bech, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000448810 · Cited by 41
Self-citationApplied psychometrics in clinical psychiatry: the pharmacopsychometric triangle
Bech, P. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01445.x · Cited by 38
Self-citationWell-Being: An Important Concept for Psychotherapy and Psychiatric Neuroscience
Hasler, G. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447268 · Cited by 36
The General Neurotic Syndrome: A Re-Evaluation
Tyrer, P., Tyrer, H., & Guo, B. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000444196 · Cited by 32
XII. On exorcising the ghost of Gauss and the curse of Kelvin
Feinstein, A. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt19711261003 · Cited by 26
The hidden costs of financial conflicts of interest in medicine
Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000442694 · Cited by 25
Self-citationMeasuring euthymia within the Neuroticism Scale from the NEO Personality Inventory
Bech, P., Carrozzino, D., Austin, S. F., Møller, S. B., & Vassend, O. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.039 · Cited by 25
Self-citationConflict of Interest in Psychopharmacology: Can Dr. Jekyll Still Control Mr. Hyde?
Fava, G. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000074433 · Cited by 24
Self-citationGeneral Problems of Psychiatric Rating Scales (Especially for Depression)
Hamilton, M. (2015) · Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry · doi:10.1159/000395072 · Cited by 24
DiMascio, A., & Shader, R. I. (1968) · PubMed · Cited by 15
Adverse Psychiatric Reactions to Modern Medication
Whitlock, F. A. (1981) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048678109159417 · Cited by 15
Emerging trends in clinical psychology
Guidi, J., & Fava, G. A. (2014) · Rivista di psichiatria · doi:10.1708/1766.19118 · Cited by 11
Self-citationBech, P., & Rickels, K. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000444454 · Cited by 8
Self-citationHamilton, M. (1968) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2987161 · Cited by 8
Rodriguez-Urrutia, A., Eiroa-Orosa, F. J., Accarino, A., Malagelada, C., & Azpiroz, F. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000443899 · Cited by 6
Iatrogenic comorbidity in mental health
Fava, G. A., Cosci, F., & Tomba, E. (2015) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · Cited by 6
Self-citationFava, G. A., Staccini, L., Chiaie, R. D., Belaise, C., & Tomba, E. (2014) · Rivista di psichiatria · doi:10.1708/1668.18270 · Cited by 5
Self-citation
Research works printed but not linked: 3
- 2 Bech P: Clinical Psychometrics. Oxford, Wiley-Blackwell, 2012.
- 3 Pichot P: Introduction; in Pichot P (ed): Psychological Measurements in Psychopharmacology. Basel, Karger, 1974, pp 1-7.
- 10 Feinstein AR: Clinimetrics. New Haven, Yale University Press, 1987.
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Carrozzino, D., Patierno, C., Fava, G. A., & Guidi, J. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506879 · Cited by 263
Self-citationFava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
Self-citationMethodological Recommendations for Trials of Psychological Interventions
Guidi, J., Brakemeier, E.-L., Bockting, C. L. H., Cosci, F., Cuijpers, P., Jarrett, R. B., Linden, M., Marks, I., Peretti, C. S., Rafanelli, C., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000490574 · Cited by 205
Self-citationClinimetric Criteria for Patient-Reported Outcome Measures
Carrozzino, D., Patierno, C., Guidi, J., Berrocal Montiel, C., Cao, J., Charlson, M. E., Christensen, K. S., Concato, J., De las Cuevas, C., de Leon, J., et al. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000516599 · Cited by 177
Self-citation
Metadata
- Authors
- Fava, G. A., Tomba, E., & Bech, P.
- Affiliations
- University of Bologna (IT)
- Copenhagen University Hospital (DK)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 86
- Issue
- 3
- Pages
- 134-140
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2613087407
- Semantic Scholar
- 9566edfc2f854e96b5dd99691a6b765940a319de
- Cited by
- 52
- References
- 76
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 7 · 2023: 4 · 2021: 6 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 5
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Keywords
- psychotropic drugs, adverse drug reactions, behavioral toxicity, treatment response, clinimetrics, quality of life, well-being
- MeSH terms
- Mental Disorders, Humans, Psychopharmacology, Psychotherapy, Psychotropic Drugs, Quality of Life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.